Home » Topics » BioWorld Science

BioWorld Science
RSS

IDMC recommends stopping phase III COMET-ICE trial of VIR-7831 early for efficacy

March 11, 2021

Dosing initiates in first-in-human study of IMP-7068 in advanced solid tumors

March 11, 2021

Modus Therapeutics to initiate clinical development of sevuparin in sepsis and septic shock

March 11, 2021

Adicet Bio initiates first-in-human phase I trial of ADI-001

March 11, 2021

DemeRx receives approval for phase I/II study of ibogaine in the U.K.

March 11, 2021

Maavrx patents TH- and GCH1-encoding genetic constructs for PD

March 11, 2021

Novartis identifies new NSD2 inhibitors

March 11, 2021

Dr Reddy's Institute of Life Sciences patents 5-HT2C receptor PAAMs

March 11, 2021

Bristol Myers Squibb discloses new IRAK-4 inhibitors

March 11, 2021

Millendo Therapeutics patents tachykinin NK3 receptor antagonists

March 11, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...